Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cell Transplant in Multiple Myeloma
NCT00004165Phase 3Completed
- Sponsor
- Northwestern University
- Start
- Oct 1999
- Primary completion
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of melphalan in multiple myeloma (MM), sponsored by Northwestern University. Primary endpoints: Safety of High Dose Melphalan, Cost Effectiveness of PBSC Collection and 1 more. Started Oct 1999; status: completed.
02
Drugs
melphalan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00004165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004165.